Thromboxane A2 receptors mediate pulmonary hypertension in 60% oxygen-exposed newborn rats by a cyclooxygenase-independent mechanism

Robert P. Jankov, Rosetta Belcastro, Emira Ovcina, Julia Lee, Hamid Massaeli, Stephen J. Lye, A. Keith Tanswell

Research output: Contribution to journalArticle

45 Citations (Scopus)

Abstract

Endothelin-1 (ET-1) mediates the development of pulmonary hypertension (PHT) in newborn rats exposed to 60% O2 for 14 days, a model for human chronic neonatal lung iniury. ET-1 production by d-14 rat pulmonary artery smooth muscle cells in vitro was markedly increased by thromboxane (TX) A2 receptor agonists and inhibited by a competitive antagonist. We hypothesized that stimulation of the TX A2 receptor contributed to O2-mediated PHT in vivo. Newborn rat pups received daily intraperitoneal injections of L670596, a competitive TX A2 receptor antagonist, or 5,5-dimethyl-3-(3-fluorophenyl)4-(4-methylsulfonyl)phenyl-2(5H)-furanone (DFU), a cyclooxygenase-2 inhibitor, during 14 days of 60% O2 or air exposure. L670596, but not DFU, prevented 60% O2-mediated right ventricular and small pulmonary vessel smooth muscle hypertrophy. Lung ET-1 content was significantly reduced by L670596 in 60% O2-exposed animals. We conclude that TX A2 receptor activation, though not by TX A2, caused upregulation of ET-1 and PHT in this model. A likely mediator is the stable lipid peroxidation product, 8-iso-prostane, which acts as an incidental ligand of the TX A2 receptor and is a potent inducer of ET-1 production by cultured d-14 rat pulmonary artery smooth muscle cells in vitro.

Original languageEnglish
Pages (from-to)208-214
Number of pages7
JournalAmerican Journal of Respiratory and Critical Care Medicine
Volume166
Issue number2
DOIs
Publication statusPublished - 15 Jul 2002
Externally publishedYes

Fingerprint

Prostaglandin H2 Receptors Thromboxane A2
L 670596
Endothelin-1
Prostaglandin-Endoperoxide Synthases
Pulmonary Hypertension
Oxygen
Lung
Pulmonary Artery
Smooth Muscle Myocytes
Thromboxane A2
Cyclooxygenase 2 Inhibitors
Intraperitoneal Injections
Hypertrophy
Lipid Peroxidation
Smooth Muscle
Up-Regulation
Air
Ligands

Keywords

  • 8-isoprostane
  • Endothelin-1
  • Pulmonary oxygen toxicity
  • Reactive oxygen species

ASJC Scopus subject areas

  • Pulmonary and Respiratory Medicine
  • Critical Care and Intensive Care Medicine

Cite this

Thromboxane A2 receptors mediate pulmonary hypertension in 60% oxygen-exposed newborn rats by a cyclooxygenase-independent mechanism. / Jankov, Robert P.; Belcastro, Rosetta; Ovcina, Emira; Lee, Julia; Massaeli, Hamid; Lye, Stephen J.; Keith Tanswell, A.

In: American Journal of Respiratory and Critical Care Medicine, Vol. 166, No. 2, 15.07.2002, p. 208-214.

Research output: Contribution to journalArticle

Jankov, Robert P. ; Belcastro, Rosetta ; Ovcina, Emira ; Lee, Julia ; Massaeli, Hamid ; Lye, Stephen J. ; Keith Tanswell, A. / Thromboxane A2 receptors mediate pulmonary hypertension in 60% oxygen-exposed newborn rats by a cyclooxygenase-independent mechanism. In: American Journal of Respiratory and Critical Care Medicine. 2002 ; Vol. 166, No. 2. pp. 208-214.
@article{467fd5021c324dc0873cfc7d5d0b9e0f,
title = "Thromboxane A2 receptors mediate pulmonary hypertension in 60{\%} oxygen-exposed newborn rats by a cyclooxygenase-independent mechanism",
abstract = "Endothelin-1 (ET-1) mediates the development of pulmonary hypertension (PHT) in newborn rats exposed to 60{\%} O2 for 14 days, a model for human chronic neonatal lung iniury. ET-1 production by d-14 rat pulmonary artery smooth muscle cells in vitro was markedly increased by thromboxane (TX) A2 receptor agonists and inhibited by a competitive antagonist. We hypothesized that stimulation of the TX A2 receptor contributed to O2-mediated PHT in vivo. Newborn rat pups received daily intraperitoneal injections of L670596, a competitive TX A2 receptor antagonist, or 5,5-dimethyl-3-(3-fluorophenyl)4-(4-methylsulfonyl)phenyl-2(5H)-furanone (DFU), a cyclooxygenase-2 inhibitor, during 14 days of 60{\%} O2 or air exposure. L670596, but not DFU, prevented 60{\%} O2-mediated right ventricular and small pulmonary vessel smooth muscle hypertrophy. Lung ET-1 content was significantly reduced by L670596 in 60{\%} O2-exposed animals. We conclude that TX A2 receptor activation, though not by TX A2, caused upregulation of ET-1 and PHT in this model. A likely mediator is the stable lipid peroxidation product, 8-iso-prostane, which acts as an incidental ligand of the TX A2 receptor and is a potent inducer of ET-1 production by cultured d-14 rat pulmonary artery smooth muscle cells in vitro.",
keywords = "8-isoprostane, Endothelin-1, Pulmonary oxygen toxicity, Reactive oxygen species",
author = "Jankov, {Robert P.} and Rosetta Belcastro and Emira Ovcina and Julia Lee and Hamid Massaeli and Lye, {Stephen J.} and {Keith Tanswell}, A.",
year = "2002",
month = "7",
day = "15",
doi = "10.1164/rccm.200112-124OC",
language = "English",
volume = "166",
pages = "208--214",
journal = "American Journal of Respiratory and Critical Care Medicine",
issn = "1073-449X",
publisher = "American Thoracic Society",
number = "2",

}

TY - JOUR

T1 - Thromboxane A2 receptors mediate pulmonary hypertension in 60% oxygen-exposed newborn rats by a cyclooxygenase-independent mechanism

AU - Jankov, Robert P.

AU - Belcastro, Rosetta

AU - Ovcina, Emira

AU - Lee, Julia

AU - Massaeli, Hamid

AU - Lye, Stephen J.

AU - Keith Tanswell, A.

PY - 2002/7/15

Y1 - 2002/7/15

N2 - Endothelin-1 (ET-1) mediates the development of pulmonary hypertension (PHT) in newborn rats exposed to 60% O2 for 14 days, a model for human chronic neonatal lung iniury. ET-1 production by d-14 rat pulmonary artery smooth muscle cells in vitro was markedly increased by thromboxane (TX) A2 receptor agonists and inhibited by a competitive antagonist. We hypothesized that stimulation of the TX A2 receptor contributed to O2-mediated PHT in vivo. Newborn rat pups received daily intraperitoneal injections of L670596, a competitive TX A2 receptor antagonist, or 5,5-dimethyl-3-(3-fluorophenyl)4-(4-methylsulfonyl)phenyl-2(5H)-furanone (DFU), a cyclooxygenase-2 inhibitor, during 14 days of 60% O2 or air exposure. L670596, but not DFU, prevented 60% O2-mediated right ventricular and small pulmonary vessel smooth muscle hypertrophy. Lung ET-1 content was significantly reduced by L670596 in 60% O2-exposed animals. We conclude that TX A2 receptor activation, though not by TX A2, caused upregulation of ET-1 and PHT in this model. A likely mediator is the stable lipid peroxidation product, 8-iso-prostane, which acts as an incidental ligand of the TX A2 receptor and is a potent inducer of ET-1 production by cultured d-14 rat pulmonary artery smooth muscle cells in vitro.

AB - Endothelin-1 (ET-1) mediates the development of pulmonary hypertension (PHT) in newborn rats exposed to 60% O2 for 14 days, a model for human chronic neonatal lung iniury. ET-1 production by d-14 rat pulmonary artery smooth muscle cells in vitro was markedly increased by thromboxane (TX) A2 receptor agonists and inhibited by a competitive antagonist. We hypothesized that stimulation of the TX A2 receptor contributed to O2-mediated PHT in vivo. Newborn rat pups received daily intraperitoneal injections of L670596, a competitive TX A2 receptor antagonist, or 5,5-dimethyl-3-(3-fluorophenyl)4-(4-methylsulfonyl)phenyl-2(5H)-furanone (DFU), a cyclooxygenase-2 inhibitor, during 14 days of 60% O2 or air exposure. L670596, but not DFU, prevented 60% O2-mediated right ventricular and small pulmonary vessel smooth muscle hypertrophy. Lung ET-1 content was significantly reduced by L670596 in 60% O2-exposed animals. We conclude that TX A2 receptor activation, though not by TX A2, caused upregulation of ET-1 and PHT in this model. A likely mediator is the stable lipid peroxidation product, 8-iso-prostane, which acts as an incidental ligand of the TX A2 receptor and is a potent inducer of ET-1 production by cultured d-14 rat pulmonary artery smooth muscle cells in vitro.

KW - 8-isoprostane

KW - Endothelin-1

KW - Pulmonary oxygen toxicity

KW - Reactive oxygen species

UR - http://www.scopus.com/inward/record.url?scp=0037099166&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0037099166&partnerID=8YFLogxK

U2 - 10.1164/rccm.200112-124OC

DO - 10.1164/rccm.200112-124OC

M3 - Article

VL - 166

SP - 208

EP - 214

JO - American Journal of Respiratory and Critical Care Medicine

JF - American Journal of Respiratory and Critical Care Medicine

SN - 1073-449X

IS - 2

ER -